Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit momentum in its Biotechnology and Life Sciences segments. Post navigation Previous Previous post: OpenAI Is Working With Consultants to Sell CodexNext Next post: D.R. Horton Posts Lower Profit Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Seven more arrested after arson attacks on London Jewish sites 0 Olly Robbins says he faced ‘constant pressure’ to get Mandelson in post 0
